Search research articles
Contact Us
Filters
Showing results (531-540 of 595) with videos related to
Page
of 60
Sort By:
International Journal of Biological Sciences
|
January 9, 2025
Tubulointerstitial nephritis antigen-like 1 promotes the progression of liver fibrosis after HCV eradication with direct-acting antivirals
Lei Lei, Hu Li, Xue-Kai Wang, et al.
Cancer Letters
|
September 5, 2025
Phenotyping and Clinical Utility of Phagocytic Polyploid Giant Cancer Macrophages in Blood
Daniel L Adams, Massimo Cristofanilli, Steven H Lin, et al.
Age and Ageing
|
January 25, 2025
A mobile interactive cognitive self-assessment scale for screening cognitive impairment due to Alzheimer's disease
Kexin Xie, Juan Huang, Ting Chen, et al.
Angiogenesis
|
July 6, 2016
Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats
Jin-Hang Gao, Shi-Lei Wen, Shi Feng, et al.
Oncotarget
|
January 7, 2017
Prevalence of psychological symptoms among Ebola survivors and healthcare workers during the 2014-2015 Ebola outbreak in Sierra Leone: a cross-sectional study
Dong Ji, Ying-Jie Ji, Xue-Zhang Duan, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
October 5, 2015
Elevated OCT1 participates in colon tumorigenesis and independently predicts poor prognoses of colorectal cancer patients
Yu-Peng Wang, Guo-He Song, Jian Chen, et al.
Experimental Biology and Medicine (Maywood, N.J.)
|
October 15, 2011
Biglycan expression correlates with aggressiveness and poor prognosis of gastric cancer
Bin Wang, Guang-Xin Li, Shu-Guang Zhang, et al.
Heliyon
|
January 18, 2024
KLK10/LIPH/PARD6B/SLC52A3 are promising molecular biomarkers for the prognosis of pancreatic cancer through a ceRNA network
Meng Zhang, Lin Jiang, Xin-Yun Liu, et al.
British Journal of Cancer
|
October 5, 2020
A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer
Benjamin C Creelan, Tammie C Yeh, Sang-We Kim, et al.
Clinical Pharmacokinetics
|
April 12, 2024
Clinical Pharmacology of the Antibody-Drug Conjugate Enfortumab Vedotin in Advanced Urothelial Carcinoma and Other Malignant Solid Tumors
Mei Tang, Amit Garg, Peter L Bonate, et al.
Page
of 60
Search research articles
Search
Showing results (531-540 of 595) with videos related to
Sort By:
Page
of 60
International Journal of Biological Sciences
|
January 9, 2025
Tubulointerstitial nephritis antigen-like 1 promotes the progression of liver fibrosis after HCV eradication with direct-acting antivirals
Lei Lei, Hu Li, Xue-Kai Wang, et al.
Cancer Letters
|
September 5, 2025
Phenotyping and Clinical Utility of Phagocytic Polyploid Giant Cancer Macrophages in Blood
Daniel L Adams, Massimo Cristofanilli, Steven H Lin, et al.
Age and Ageing
|
January 25, 2025
A mobile interactive cognitive self-assessment scale for screening cognitive impairment due to Alzheimer's disease
Kexin Xie, Juan Huang, Ting Chen, et al.
Angiogenesis
|
July 6, 2016
Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats
Jin-Hang Gao, Shi-Lei Wen, Shi Feng, et al.
Oncotarget
|
January 7, 2017
Prevalence of psychological symptoms among Ebola survivors and healthcare workers during the 2014-2015 Ebola outbreak in Sierra Leone: a cross-sectional study
Dong Ji, Ying-Jie Ji, Xue-Zhang Duan, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
October 5, 2015
Elevated OCT1 participates in colon tumorigenesis and independently predicts poor prognoses of colorectal cancer patients
Yu-Peng Wang, Guo-He Song, Jian Chen, et al.
Experimental Biology and Medicine (Maywood, N.J.)
|
October 15, 2011
Biglycan expression correlates with aggressiveness and poor prognosis of gastric cancer
Bin Wang, Guang-Xin Li, Shu-Guang Zhang, et al.
Heliyon
|
January 18, 2024
KLK10/LIPH/PARD6B/SLC52A3 are promising molecular biomarkers for the prognosis of pancreatic cancer through a ceRNA network
Meng Zhang, Lin Jiang, Xin-Yun Liu, et al.
British Journal of Cancer
|
October 5, 2020
A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer
Benjamin C Creelan, Tammie C Yeh, Sang-We Kim, et al.
Clinical Pharmacokinetics
|
April 12, 2024
Clinical Pharmacology of the Antibody-Drug Conjugate Enfortumab Vedotin in Advanced Urothelial Carcinoma and Other Malignant Solid Tumors
Mei Tang, Amit Garg, Peter L Bonate, et al.
Page
of 60